Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis

Chitinase-3-like protein 1 (YKL-40) is suggested to be associated with type 2 T helper response and atopy. The aim of the study was the evaluation of serum YKL-40 level in atopic dermatitis. The study was performed on 59 patients: 27 males and 32 females, aged from 18 to 64 years. The severity of the disease was assessed by the SCORAD and objective SCORAD indexes. The severity of pruritus was measured by the visual analogue scale. Blood samples were taken to examine serum level of YKL-40, total IgE level, C-reactive protein level, white blood cell count, and neutrophil count. YKL-40 serum levels were significantly higher in patients with atopic dermatitis compared to the controls. There was a positive correlation between YKL-40 concentration and SCORAD, objective SCORAD, and pruritus. This study has shown that YKL-40 serum level is increased in patients with atopic dermatitis and reflects the severity of symptoms.

[1]  R. Sarpong,et al.  Bio-inspired synthesis of xishacorenes A, B, and C, and a new congener from fuscol† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc02572c , 2019, Chemical science.

[2]  C. Akdis,et al.  Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. , 2016, The Journal of allergy and clinical immunology.

[3]  Anton P. Bussink,et al.  New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma , 2016, Current Allergy and Asthma Reports.

[4]  J. Kere,et al.  Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease. , 2016, American journal of respiratory and critical care medicine.

[5]  A. Heratizadeh,et al.  Der p1 and Der p2-Specific T Cells Display a Th2, Th17, and Th2/Th17 Phenotype in Atopic Dermatitis. , 2015, The Journal of investigative dermatology.

[6]  E. Jassem,et al.  YKL-40 Protein Correlates with the Phenotype of Asthma , 2015, Lung.

[7]  S. Kaesler,et al.  The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments , 2015, Seminars in Immunopathology.

[8]  H. Akbari,et al.  YKL-40 in Asthma and its correlation with different clinical parameters. , 2014, Iranian journal of allergy, asthma, and immunology.

[9]  S. Durham,et al.  Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. , 2014, The Journal of allergy and clinical immunology.

[10]  G. Ogg,et al.  A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis , 2013, The Journal of experimental medicine.

[11]  Se Jin Park,et al.  Increased Expression of YKL-40 in Mild and Moderate/Severe Persistent Allergic Rhinitis and its Possible Contribution to Remodeling of Nasal Mucosa , 2013, American journal of rhinology & allergy.

[12]  A. Mandal,et al.  Diverse pathological implications of YKL-40: answers may lie in 'outside-in' signaling. , 2013, Cellular signalling.

[13]  E. James,et al.  Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. , 2012, The Journal of allergy and clinical immunology.

[14]  W. Marsden.  I and J , 2012 .

[15]  J. W. Park,et al.  YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma. , 2012, Journal of investigational allergology & clinical immunology.

[16]  B. Ma,et al.  Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. , 2011, Annual review of physiology.

[17]  J. Elias,et al.  Role of breast regression protein-39/YKL-40 in asthma and allergic responses , 2009, Allergy, asthma & immunology research.

[18]  T. Hansen,et al.  Association of Polymorphisms of the CHI3L1 Gene with Asthma and Atopy: A Populations-Based Study of 6514 Danish Adults , 2009, PloS one.

[19]  R. Flavell,et al.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis , 2009, The Journal of experimental medicine.

[20]  Min Goo Lee,et al.  Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. , 2009, American journal of respiratory and critical care medicine.

[21]  C. Lee.  Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling , 2009, Yonsei medical journal.

[22]  Y. Erzin,et al.  Serum YKL‐40 as a marker of disease activity and stricture formation in patients with Crohn's disease , 2008, Journal of gastroenterology and hepatology.

[23]  Ying Sun,et al.  Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. , 2008, The New England journal of medicine.

[24]  J. Dziura,et al.  A chitinase-like protein in the lung and circulation of patients with severe asthma. , 2007, The New England journal of medicine.

[25]  D. Speijer,et al.  Evolution of Mammalian Chitinase(-Like) Members of Family 18 Glycosyl Hydrolases , 2007, Genetics.

[26]  D. Nielsen,et al.  Serum YKL-40, A New Prognostic Biomarker in Cancer Patients? , 2006, Cancer Epidemiology Biomarkers & Prevention.

[27]  K. Ostergaard,et al.  Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. , 2001, Osteoarthritis and cartilage.

[28]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[29]  A. Taïeb,et al.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. , 1993, Dermatology.

[30]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[31]  H. Ludwig.  Chitin , 2022 .